These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 29735632

  • 1. Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging.
    De Silva TM, Li Y, Kinzenbaw DA, Sigmund CD, Faraci FM.
    Hypertension; 2018 Jul; 72(1):227-234. PubMed ID: 29735632
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress.
    Mukohda M, Stump M, Ketsawatsomkron P, Hu C, Quelle FW, Sigmund CD.
    Am J Physiol Heart Circ Physiol; 2016 Jan 01; 310(1):H39-48. PubMed ID: 26566726
    [Abstract] [Full Text] [Related]

  • 6. Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Protects From Angiotensin II-Induced Endothelial Dysfunction in Adult Offspring Born From Pregnancies Complicated by Hypertension.
    Nair AR, Silva SD, Agbor LN, Wu J, Nakagawa P, Mukohda M, Lu KT, Sandgren JA, Pierce GL, Santillan MK, Grobe JL, Sigmund CD.
    Hypertension; 2019 Jul 01; 74(1):173-183. PubMed ID: 31104564
    [Abstract] [Full Text] [Related]

  • 7. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
    Marchesi C, Rehman A, Rautureau Y, Kasal DA, Briet M, Leibowitz A, Simeone SM, Ebrahimian T, Neves MF, Offermanns S, Gonzalez FJ, Paradis P, Schiffrin EL.
    Cardiovasc Res; 2013 Mar 01; 97(3):562-70. PubMed ID: 23250918
    [Abstract] [Full Text] [Related]

  • 8. Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production.
    Kleinhenz JM, Kleinhenz DJ, You S, Ritzenthaler JD, Hansen JM, Archer DR, Sutliff RL, Hart CM.
    Am J Physiol Heart Circ Physiol; 2009 Nov 01; 297(5):H1647-54. PubMed ID: 19666848
    [Abstract] [Full Text] [Related]

  • 9. Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.
    Beyer AM, de Lange WJ, Halabi CM, Modrick ML, Keen HL, Faraci FM, Sigmund CD.
    Circ Res; 2008 Sep 12; 103(6):654-61. PubMed ID: 18676352
    [Abstract] [Full Text] [Related]

  • 10. Interference With Endothelial PPAR (Peroxisome Proliferator-Activated Receptor)-γ Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation.
    Nair AR, Agbor LN, Mukohda M, Liu X, Hu C, Wu J, Sigmund CD.
    Hypertension; 2018 Nov 12; 72(5):1227-1235. PubMed ID: 30354810
    [Abstract] [Full Text] [Related]

  • 11. Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle.
    Pelham CJ, Keen HL, Lentz SR, Sigmund CD.
    Am J Physiol Regul Integr Comp Physiol; 2013 May 01; 304(9):R690-701. PubMed ID: 23447133
    [Abstract] [Full Text] [Related]

  • 12. Changes in Cerebral Arteries and Parenchymal Arterioles With Aging: Role of Rho Kinase 2 and Impact of Genetic Background.
    De Silva TM, Modrick ML, Dabertrand F, Faraci FM.
    Hypertension; 2018 May 01; 71(5):921-927. PubMed ID: 29531174
    [Abstract] [Full Text] [Related]

  • 13. Endothelial PPAR-γ protects against vascular thrombosis by downregulating P-selectin expression.
    Jin H, Gebska MA, Blokhin IO, Wilson KM, Ketsawatsomkron P, Chauhan AK, Keen HL, Sigmund CD, Lentz SR.
    Arterioscler Thromb Vasc Biol; 2015 Apr 01; 35(4):838-44. PubMed ID: 25675995
    [Abstract] [Full Text] [Related]

  • 14. Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation.
    De Silva TM, Modrick ML, Ketsawatsomkron P, Lynch C, Chu Y, Pelham CJ, Sigmund CD, Faraci FM.
    Hypertension; 2014 Nov 01; 64(5):1088-93. PubMed ID: 25185134
    [Abstract] [Full Text] [Related]

  • 15. Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK.
    Uddin MS, Kabir MT, Jakaria M, Mamun AA, Niaz K, Amran MS, Barreto GE, Ashraf GM.
    Neurotox Res; 2019 Oct 01; 36(3):583-601. PubMed ID: 31055770
    [Abstract] [Full Text] [Related]

  • 16. Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
    Hasan DM, Starke RM, Gu H, Wilson K, Chu Y, Chalouhi N, Heistad DD, Faraci FM, Sigmund CD.
    Hypertension; 2015 Jul 01; 66(1):211-20. PubMed ID: 25916724
    [Abstract] [Full Text] [Related]

  • 17. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy.
    Schrader LI, Kinzenbaw DA, Johnson AW, Faraci FM, Didion SP.
    Arterioscler Thromb Vasc Biol; 2007 Dec 01; 27(12):2576-81. PubMed ID: 17962626
    [Abstract] [Full Text] [Related]

  • 18. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
    Hwang J, Kleinhenz DJ, Rupnow HL, Campbell AG, Thulé PM, Sutliff RL, Hart CM.
    Vascul Pharmacol; 2007 Jun 01; 46(6):456-62. PubMed ID: 17337254
    [Abstract] [Full Text] [Related]

  • 19. Vascular smooth muscle cell peroxisome proliferator-activated receptor γ protects against endothelin-1-induced oxidative stress and inflammation.
    Idris-Khodja N, Ouerd S, Trindade M, Gornitsky J, Rehman A, Barhoumi T, Offermanns S, Gonzalez FJ, Neves MF, Paradis P, Schiffrin EL.
    J Hypertens; 2017 Jul 01; 35(7):1390-1401. PubMed ID: 28234672
    [Abstract] [Full Text] [Related]

  • 20. Age-related differences in the effects of α and γ peroxisome proliferator-activated receptor subtype agonists on endothelial vasodilation in human microvessels.
    Angulo J, Vallejo S, El Assar M, García-Septiem J, Sánchez-Ferrer CF, Rodríguez-Mañas L.
    Exp Gerontol; 2012 Sep 01; 47(9):734-40. PubMed ID: 22776133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.